KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Acquisitions: 2013-2014

Historic Acquisitions for Sarepta Therapeutics (SRPT) over the last 1 years, with Mar 2014 value amounting to $2.4 million.

  • Sarepta Therapeutics' Acquisitions was N/A to $2.4 million in Q1 2014 from the same period last year, while for Mar 2014 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $172.6 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q1 2014, Sarepta Therapeutics' Acquisitions is $2.4 million, which was down 0.00% from $2.4 million recorded in Q4 2013.
  • In the past 5 years, Sarepta Therapeutics' Acquisitions registered a high of $2.4 million during Q2 2013, and its lowest value of $2.4 million during Q2 2013.
  • Over the past 2 years, Sarepta Therapeutics' median Acquisitions value was $2.4 million (recorded in 2014), while the average stood at $2.4 million.